Gilead Sciences, Inc. has appointed Cindy Perettie Executive Vice President of Kite, a Gilead Company, overseeing the cell therapy business, and will become a member of Gilead’s senior leadership team, effective May 30.   Ms. Perettie brings extensive experience in oncology. Most recently, she was Head of Roche’s Molecular Lab Solutions where she oversaw the PCR (polymerase chain reaction) and Sequencing Business. Prior to that, she was Chief Executive Officer at Foundation Medicine.    Ms. ...